Both Alert and Dilantin offer similar effectiveness in symptom control, with the main difference being how quickly they act. Either drug is a viable option depending on the patient’s needs.

Both Alert and Dilantin have similar safety profiles, with mild and transient side effects. Neither presents significant long-term safety concerns.

Dilantin has a more stable therapeutic effect and is less likely to lead to dependency or cravings compared to Alert.

Both Alert and Dilantin are easy to use, with straightforward dosing regimens that ensure good adherence.

Dilantin is better for patients with cardiovascular or diabetes-related issues, as it has fewer interactions with other medications.

Dilantin is better suited for chronic conditions, offering longer-lasting effects and a favorable safety profile for long-term use. Its flexibility in administration makes it a strong option for various patient needs.